ReleaseWire

Global Markets Direct's, 'Diabetic Neuropathic Pain - Pipeline Review, H2 2014', provides an overview of the Diabetic Neuropathic Pain's therapeutic pipeline.

GlobalData's clinical trial report, "Renal Artery Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Renal Artery Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Artery Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Artery Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Presidio Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Kyorin Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Asthma - Pipeline Review, H2 2014', provides an overview of the Asthma's therapeutic pipeline.

Global Markets Direct's, 'Insulin Resistance - Pipeline Review, H2 2014', provides an overview of the Insulin Resistance's therapeutic pipeline.

Global Markets Direct's, 'Hypercholesterolemia - Pipeline Review, H2 2014', provides an overview of the Hypercholesterolemia's therapeutic pipeline.

Global Markets Direct's, 'Fatty Liver Disease - Pipeline Review, H2 2014', provides an overview of the Fatty Liver Disease's therapeutic pipeline.

Global Markets Direct's, 'Huntington's Disease - Pipeline Review, H2 2014', provides an overview of the Huntington's Disease's therapeutic pipeline.

Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, and Albert Einstein College of Medicine of Yeshiva University, a research-intensive medical school in Bronx, NY, started development of an antibody construct labeled with actinium 225 using a novel technology that potentially allows for the expansion of use of the Company’s proprietary platform, and enables further manufacturing improvements of alpha therapy technology based drug candidates. The first antibody to be labeled using the new technology has potential to be broadly used in the field of hematology/oncology. Preclinical studies of the new technology have demonstrated significant improvements in product’s manufacturing while maintaining biological integrity and properties of labeled antibodies.

GlobalData has released its pharma report, "PharmaPoint: Acute Coronary Syndrome - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing ACS Market. The report identifies and analyses the key companies shaping and driving the global ACS market. The report provides insight into the competitive ACS landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'NeurAxon, Inc. - Product Pipeline Review - 2014', provides an overview of the NeurAxon, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Polycystic Ovarian Syndrome - Pipeline Review, H2 2014', provides an overview of the Polycystic Ovarian Syndrome's therapeutic pipeline.

Global Markets Direct's, 'Lymphangioleiomyomatosis - Pipeline Review, H2 2014', provides an overview of the Lymphangioleiomyomatosis's therapeutic pipeline.

OTC Medications in Colombia by Mintel Market Sizes provides you with annual year-end market size data, most recently updated in 2014. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies and vitamins and minerals. It excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Colombia is given in COP with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for Colombia. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.

Global Markets Direct's, 'Memgen, LLC. - Product Pipeline Review - 2014', provides an overview of the Memgen, LLC.'s pharmaceutical research and development focus.

OTC Medications in India by Mintel Market Sizes provides you with annual year-end market size data, most recently updated in 2014. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies and vitamins and minerals. It excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in India is given in INR with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for India. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.

Global Markets Direct's, 'ContraFect Corporation - Product Pipeline Review - 2014', provides an overview of the ContraFect Corporation's pharmaceutical research and development focus.

Global Markets Direct's, 'Heart Attack - Pipeline Review, H2 2014', provides an overview of the Heart Attack's therapeutic pipeline.

Global Markets Direct's, 'Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014', provides an overview of the Functional (Non Ulcer) Dyspepsia's therapeutic pipeline.

OTC Medications in UK by Mintel Market Sizes provides you with annual year-end market size data, most recently updated in 2014. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies and vitamins and minerals. It excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in UK is given in GBP with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for UK. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.

Global Markets Direct's, 'Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014', provides an overview of the Arbor Pharmaceuticals, LLC.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Cerebral Palsy - Pipeline Review, H2 2014', provides an overview of the Cerebral Palsy's therapeutic pipeline.

Global Markets Direct's, 'Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014', provides an overview of the Relapsing Multiple Sclerosis (RMS)'s therapeutic pipeline.

Global Markets Direct's, 'Influenza B Infections - Pipeline Review, H2 2014', provides an overview of the Influenza B Infections's therapeutic pipeline.